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ChIP-SeqThe data described in this article refers to Chatterjee et al. (2015) “In vivo genome-wide analysis of multiple tis-
sues identiﬁes gene regulatory networks, novel functions and downstream regulatory genes for Bapx1 and its co-
regulation with Sox9 in the mammalian vertebral column” (GEO GSE35649) [1]. Transcriptional proﬁling com-
binedwith genomewide bindingdata is a powerful tool to elucidate themolecularmechanismbehind vertebrate
organogenesis. It also helps to uncovermultiple roles of a single gene in different organs. In the abovementioned
reportwe reveal the function of the homeobox gene Bapx1 during the embryogenesis ofﬁve distinct organs (ver-
tebral column, spleen, gut, forelimband hindlimb) at a relevant developmental stage (E12.5),microarray analysis
of isolatedwildtype andmutant cells in is compared in conjunctionwith ChIP-Seq analysis. We also analyzed the
development of the vertebral column by comparing microarray and ChIP-Seq data for Bapx1with similarly gen-
erated data sets for Sox9 to generate a gene regulatory network controlling various facets of the organogenesis.
© 2015 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).ression BeadChip
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applicable1. Direct link to deposited data
Deposited data can be found here: http://www.ncbi.nlm.nih.gov/
geo/query/acc.cgi?acc=GSE35649.. This is an open access article under2. Data, experimental design, materials and methods
2.1. Overall experimental strategy
The data presented here pertains to Chatterjee et al. (2015) “In vivo
genome-wide analysis of multiple tissues identiﬁes gene regulatory
networks, novel functions and downstream regulatory genes for
Bapx1 and its co-regulation with Sox9 in the mammalian vertebral col-
umn.” [1]. We have used stable transgenic mouse lines expressing EGFP
under the endogenous promoter of various transcription factors
expressed in various organs in the developing embryo to sort out cells
to do further genomic experiments like transcriptional proﬁling and ge-
nomewide binding assays (Fig. 1). The study shows the utility of such a
method for studying gene regulatory networks in a speciﬁc cell popula-
tion of particular organ as marked by speciﬁc transcription factors.
2.2. Transgenic mouse generation
The murine BAC clone RP24-148P5 containing genomic DNA
from C57BL/6 J ﬂanking the Bapx1 gene was obtained from the
BACPAC Resources Centre at Children's Hospital Oakland Research
Institute (CHORI) and targeting constructs were generated via the
Quick and Easy BAC modiﬁcation kit (Gene Bridges) according to
the manufacturer's protocols. The Bapx1tm2.Tlu allele was generated
as previously reported [2] to create wildtype mice expressing EGFPthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1.Workﬂow for cell-type speciﬁc transcriptional proﬁling via combined transgenic and genomics approaches. GeneX represent any gene of interest. In the case described here it is
Bapx1. GeneX is inactivated by insertion of EGFP into the coding sequence by homologous recombination in embryonic stem (ES) cells. Chimeric animals which are able to transmit the
EGFPmodiﬁed gene are generated by blastocyst injection. Embryos from germ-line transmitting chimeras or from the resulting heterozygous founder animals are used to collect embryos
for dissociation into single cells. FACS allows for the separation of EGFP positive and negative cells which are subsequently used for expession proﬁling analysis. The results of the expres-
sion proﬁling combined with the ChIP data allows for the building of the gene regulatory network (GRN). Blue boxes represent exonic sequences. P-GeneX represents the promoter of
GeneX.
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allele was generated by deleting 90 bp of the endogenous sequence by
inserting the EGFP-FRT-PGK-gb2-Neo-FRT cassette immediately up-
stream of the translational start codon of Bapx1, to create an EGFP ex-
pressing Bapx1 null. Two southern blot conﬁrmed gene targeted ES
cell clones with normal karyotype were subsequently microinjected
into 2–8-cell stage embryos isolated fromC57BL/6mice to generate chi-
meric mice as previously described [3]. The chimeric mice were bred to
wildtype mice to generate stable lines. The FRT-ﬂanking neomycin cas-
sette in the targeted Bapx1 allele was deleted out by breeding to the
FLPe–deleter mice 129S4/SvJaeSor-Gt(ROSA)26Sor tm1(FLP1)Dym/J
(Stock # 3946) from Jackson Laboratories [4,5]. Routine PCR genotyping
of Bapx1 lines was performed as essentially described in [6]. Con-
structs of a similar nature were generated for the Sox9 locus to create
Sox9tm11Tlu [7] and Sox9−/−(EGFP) mice that are to be detailed later.
2.3. Sorting EGFP expressing cells from mouse embryos
Embryos expressing EGFP in the Bapx1 or Sox9 expression domains
were identiﬁed under a ﬂuorescent dissection microscope (Leica).
Vertebral columns, spleens, guts, hindlimbs and forelimb from Bapx1
tagged line and only vertebral column from Sox9 tagged line were sep-
arately dissociated into single cells in a solution made of 100 U/ml Col-
lagenase I & II, 50U/mlDNAse and0.05% Trypsin (Invitrogen) by serially
ﬁltering them through a 100uM and 40uM cell strainer. The cell pellet
was resuspended in 5% FBS, 4 mM EDTA in Leibovitz L-15 medium for
cell sorting using FACSAria (BD Biosciences).
2.4. Gene expression microarrays and analyses
For each sorted cell population in both wildtype as well as null em-
bryos, 4 biological replicates were used to extract total RNA using TRIzol
(Invitrogen) followed by the RNeasy Micro Kit (Qiagen). Integrity of theRNAwas assessed using an Agilent 2100 Bioanalyzer (Agilent Technolo-
gies). TargetAmp™-Nano Labeling Kit for Illumina Expression BeadChip
(Epicenter Biotechnologies) was used to label 25 ng total RNA from
each sample. MouseWG-6 v2.0 Expression BeadChip microarrays
(Illumina) were used to hybridize the samples according to Illumina
guidelines. GenomeStudio software (Illumina) was used to prepare
background-subtracted data. The background-subtracted data was then
imported into Partek Genomics Suite (Agilent) for data normalization.
The probe intensities from various biological replicates were normalized
using scale normalization using median absolute deviation as a spread
measure. This was further ﬁltered on percentile (lower 20 and upper
100) by expression of probe sets without averaging over replicates.
These probe sets, which passed this ﬁlter, were further used to calculate
gene expression changes between different conditions. ANOVA with
nominal alpha value set to 0.05 was then used to determine the probe
sets signiﬁcantly different between the different genotypes compared.
To reduce the false positive rate, Benjamini and Hochberg Multiple test-
ing correction was applied, and probe sets with expression fold change
N2.0 or N1.5 between the different genotypes were selected for further
validation and analyses. Data has been deposited in Gene Expression
Omnibus (GEO) as described above. Ingenuity Pathway Analysis
(Ingenuity® Systems, www.ingenuity.com) analyses were performed
using the web-based tools.
2.5. Functional annotation of genes controlled by Bapx1 and Sox9
Our microarray analysis revealed that while Bapx1 affected a large
number of genes (with N2 fold enrichment) in the spleen (n = 980),
gut (n = 143) and vertebral column (n = 125), it controlled only
several genes in the hind- (n= 30) and forelimb (n= 2). Sox9 con-
trolled 3593 genes in the vertebral column with N1.5 fold enrich-
ment between the wildtype and the Sox9 null. Analysis of genes
controlled by Bapx1 in the Vertebral column showed enrichment of
Table 1
Signaling pathways affected by Bapx1 in the vertebral column.
Bapx1 in Vertebral column
Pathways -log (p-value)
Wnt/β-catenin Signaling 1.26
Inhibition of Matrix Metalloproteases 1.41
VEGF Signaling 1.45
Bapx1 in Spleen
Pathways -log (p-value)
FGF Signaling 1.82
ERK/MAPK Signaling 2.06
Epithelial Adherens Junction Signaling 4.2
Bapx1 in Gut
Pathways -log (p-value)
ERK/MAPK Signaling 1.61
Regulation of the Epithelial-Mesenchymal Transition Pathway 1.66
VEGF Signaling 1.79
Sox9 in Vertebral column
Pathways -log (p-value)
Differentiation of chondrocytes 5.46
Apoptosis 13.41
Proliferation of cells 27.42
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tion of matrix metalloproteases (Table 1). Similar analysis for genes
regulated by Bapx1 in the spleen showed enrichment of genes of
the FGF signaling pathway, which is critical for cell survival, differen-
tiation, morphogenesis and angiogenesis. Other enriched genes in-
cluded members of the epithelial adherens junction signaling and
ERK/MAPK signaling. Signaling pathways such as VEGF signaling,
ERK/MAPK signaling and the epithelial-mesenchymal transition
pathway were enriched in the gut similar to our observations in
the spleen. (Table 1). We also looked at the genes which are con-
trolled by Sox9 in the vertebral column which revealed that most
had known roles in chondrocyte differentiation, proliferation and
apoptosis (Table 1).
2.6. ChIP-assay and peak calling
For Bapx1 and Sox9 ChIP, vertebral columns from ~100 E12.5 (both
S-peptide tagged for Baxp1 and wildtype for Sox9) embryos were dis-
sected and 2mg of chromatinwas used for ChIP as previously described
[8] with anti S-Peptide antibody (Bethyl laboratories, A190-134A). For
Sox9 ChIP anti-Sox9 antibody (R&D Systems, AF3075) was used for im-
munoprecipitation. 10-15 ng of puriﬁed ChIP DNA from each sample
was used to synthesize the sequencing library as per manufacturer's in-
structions (Illumina). Sequence reads produced by Illumina Genome
Analyzer II/IIx that passed the signal purity ﬁltering were mapped to
themouse genomemm9, using the Illumina GenomeAnalyzer Pipeline.
All uniquelymapped reads that arewith two or fewermismatcheswere
retained. Genomic binding sites were identiﬁed using the peak calling
algorithm MACS (version 1.4.0 beta) with default settings (band
width = 300, model fold =10, 30, p-value cutoff =1.00e-05, range
for calculating regional lambda =1000 and 10,000 bps) [9]. For Bapx1
ChIP, untagged wildtype embryos were used as control and for Sox9
the input DNA was used as control. For annotation of the ChIP-Seq
peaks, ﬁrst the transcription start site (TSS) of the Refseq gene nearest
to peaks were found and reported. If the peaks resided in intragenic re-
gion of nearest gene it was called “intragenic”, otherwise “intergenic”. If
the peaks resided within 5000 bp of TSS they were called as “promoter”
peaks. All data has been deposited in Gene Expression Omnibus (GEO)
under accession number GSE35877.
We detected 2815 Bapx1 peaks with 540 of them located at the TSS
of various genes. A large proportion of the binding siteswere distal fromthe TSS, 1052 located at N25 kbdistally in the intergenic and722 located
N25 kb in the intragenic regions. Similarly for Sox9, we identiﬁed 3722
peaks.2.7. Motif analysis
Peaks called by MACS were ranked as described [1]. The top 200
peaks were used for motif analysis and the repeat masked genome
sequence +/− 50 bp from the summit of these 200 peaks was
downloaded from the UCSC genome browser (http://genome.ucsc.
edu/). We identiﬁed the Bapx1 binding motif T(G/A)AGTG [10],
enriched in about 40% of the Bapx1 binding sites in the genome specif-
ically near genes controlling cartilage and bonemorphogenesis.We also
identiﬁed the DNA bindingmotif for Sox9 (A/T)(A/T)CAA(A/T)G identi-
ﬁed mostly by in vitro studies [11].2.8. Bapx1-Sox9 interplay in vertebral column
Of the group of genes repressed by Bapx1 and activated by Sox9,
over 85% had both the Sox9 and Bapx1 binding sites within 200 kb of
their TSS. These genes represent potential primary targets of both
Bapx1 and Sox9, and under opposing regulatory control in the vertebral
column to maintain a distinct neuronal and osteo-chondrogenic identi-
ty in the developing embryo. This group includes genes like Nrn1,
Ctnna2, and Gata3 that are known neuronal genes but have so far not
been implicated to be regulated by either Sox9 or Bapx1. Over 75% of
the genes repressed by both Bapx1 and Sox9 had binding sites for
both Bapx1 and Sox9 within 200 kb of their TSS. These genes are also
potential primary targets of both Bapx1 and Sox9, but repressed by
both. This group includes the osteogenic, metalloproteinase and angio-
genesis genes Adamts4, Col1a1,Mmp11, Emcn, Nrp1 and Ctsk.References
[1] S. Chatterjee, V. Sivakamasundari, S.P. Yap, P. Kraus, V. Kumar, X. Xing, S.L. Lim, J.
Sng, S. Prabhakar, T. Lufkin, In vivo genome-wide analysis of multiple tissues iden-
tiﬁes gene regulatory networks, novel functions and downstream regulatory genes
for Bapx1 and its co-regulation with Sox9 in themammalian vertebral column. BMC
Genomics 15 (2014) 1072, http://dx.doi.org/10.1186/1471-2164-15-1072.
[2] V. Sivakamasundari, H.Y. Chan, S.P. Yap, X. Xing, P. Kraus, T. Lufkin, New Bapx1(Cre-
EGFP) Mouse Lines for Lineage Tracing and Conditional Knockout Studies. Genesis
50 (2011) 375–383, http://dx.doi.org/10.1002/dvg.20802.
[3] P. Kraus, G. Leong, V. Tan, X. Xing, J.W. Goh, S.P. Yap, T. Lufkin, A more cost effective
and rapid high percentage germ-line transmitting chimeric mouse generation pro-
cedure via microinjection of 2-cell, 4-cell, and 8-cell embryos with ES and iPS
cells. Genesis 48 (2010) 394–399, http://dx.doi.org/10.1002/dvg.20627.
[4] F.W. Farley, P. Soriano, L.S. Steffen, S.M. Dymecki, Widespread recombinase expres-
sion using FLPeR (ﬂipper) mice. Genesis 28 (2000) 106–110, http://dx.doi.org/10.
1002/1526-968X(200011/12)28:3/4.
[5] C.I. Rodriguez, F. Buchholz, J. Galloway, R. Sequerra, J. Kasper, R. Ayala, A.F. Stewart,
S.M. Dymecki, High-efﬁciency deleter mice show that FLPe is an alternative to Cre-
loxP. Nat. Genet. 25 (2000) 139–140, http://dx.doi.org/10.1038/75973.
[6] V. Sivakamasundari, H.Y. Chan, S.P. Yap, X. Xing, P. Kraus, T. Lufkin, New Bapx1Cre-
EGFP mouse lines for lineage tracing and conditional knockout studies. Genesis 50
(2012) 375–383, http://dx.doi.org/10.1002/dvg.20802.
[7] H.Y. Chan, V. Sivakamasundari, X. Xing, P. Kraus, S.P. Yap, P. Ng, S.L. Lim, T. Lufkin,
Comparison of IRES and F2A-based locus-speciﬁc multicistronic expression in stable
mouse lines. PLoS One 6 (2011)http://dx.doi.org/10.1371/journal.pone.0028885
e28885.
[8] D. Schmidt, M.D. Wilson, C. Spyrou, G.D. Brown, J. Hadﬁeld, D.T. Odom, ChIP-seq:
using high-throughput sequencing to discover protein-DNA interactions. Methods
48 (2009) 240–248, http://dx.doi.org/10.1016/j.ymeth.2009.03.001.
[9] Y. Zhang, T. Liu, C.A. Meyer, J. Eeckhoute, D.S. Johnson, B.E. Bernstein, C. Nusbaum,
R.M. Myers, M. Brown,W. Li, X.S. Liu, Model-based analysis of ChIP-Seq (MACS). Ge-
nome Biol. 9 (2008) R137, http://dx.doi.org/10.1186/gb-2008-9-9-r137.
[10] D.W. Kim, H. Kempf, R.E. Chen, A.B. Lassar, Characterization of Nkx3.2 DNA binding
speciﬁcity and its requirement for somitic chondrogenesis. J. Biol. Chem. 278 (2003)
27532–27539, http://dx.doi.org/10.1074/jbc.M301461200.
[11] Mertin, S., S.G. McDowall, V.R. Harley, The DNA-binding speciﬁcity of SOX9 and
other SOX proteins, Nucleic Acids Res., 27 (1999) 1359–1364. http://dx.doi.org/10.
1093/nar/27.5.1359
